Close Up -- Samuel Thier

Volume 5, #13The Scientist June 24, 1991 Close Up Ask Samuel Thier why he wanted to become president of Brandeis University, and he'll point to the obvious reasons--among them the high quality of its faculty, the opportunity to lead a respected research university, and the chance to return to the Boston area, where he trained and taught. With academia under attack from many quarters, Thier says he relishes the chance to show the public that universities are still vital to the co

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Ask Samuel Thier why he wanted to become president of Brandeis University, and he'll point to the obvious reasons--among them the high quality of its faculty, the opportunity to lead a respected research university, and the chance to return to the Boston area, where he trained and taught. With academia under attack from many quarters, Thier says he relishes the chance to show the public that universities are still vital to the country's well-being.

Beyond that, however, something is driving the 53-year-old former medical school department chairman back to the campus. Despite his appointment last year to a second five-year term as president of the Institute of Medicine, Thier says he can't take future success for granted. And that means grabbing a very good opportunity when it appears rather than waiting for an even better one that might never come along.

"If I could control the outside world, I'd say ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo